4.0 Article

Comorbidities in Patients with Crystal Diseases and Hyperuricemia

期刊

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.rdc.2014.01.005

关键词

Crystal arthropathies; Comorbidities; Gout; Hyperuricemia; Cardiovascular disease; Metabolic syndrome; Renal disease; Calcium pyrophosphate arthropathy

资金

  1. Savient
  2. Takeda
  3. Regeneron
  4. Allergan
  5. Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs)
  6. National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS)
  7. National-Institute of Aging (NIA)
  8. National Cancer Institute (NCI)
  9. Birmingham VA Medical Center

向作者/读者索取更多资源

Crystal arthropathies are among the most common causes of painful inflammatory arthritis. Gout, the most common example, has been associated with cardiovascular and renal disease. In recent years, evidence for these associations and those involving other comorbidities, such as the metabolic syndrome, have emerged, and the importance of asymptomatic hyperuricemia has been established. In this review, an update on evidence, both experimental and clinical, is presented, and associations between hyperuricemia, gout, and several comorbidities are described.. Causality regarding calcium pyrophosphate arthropathy and associated comorbidities is also reviewed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据